Literature DB >> 28656076

Effects of age on survival and morbidity in gastric cancer patients undergoing gastrectomy.

Yoshinori Fujiwara1, Shuichi Fukuda1, Masanori Tsujie1, Hajime Ishikawa1, Kotaro Kitani1, Keisuke Inoue1, Masao Yukawa1, Masatoshi Inoue1.   

Abstract

AIM: To evaluate clinicopathological features and surgical outcomes of gastric cancer in elderly and non-elderly patients after inverse probability of treatment weighting (IPTW) method using propensity score.
METHODS: We enrolled a total of 448 patients with histologically confirmed primary gastric carcinoma who received gastrectomies. Of these, 115 patients were aged > 80 years old (Group A), and 333 patients were aged < 79 years old (Group B). We compared the surgical outcomes and survival of the two groups after IPTW.
RESULTS: Postoperative complications, especially respiratory complications and hospital deaths, were significantly more common in Group A than in Group B (P < 0.05). Overall survival (OS) was significantly lower in Group A patients than in Group B patients. Among the subset of patients who had pathological Stage I disease, OS was significantly lower in Group A (P < 0.05) than Group B, whereas cause-specific survival was almost equal in the two groups. In multivariate analysis, pathological stage, histology, and extent of lymph node dissection were independent prognostic values for OS.
CONCLUSION: When the gastrectomy was performed in gastric cancer patients, we should recognized high mortality and comorbidities in that of elderly. More extensive lymph node dissection might improve prognoses of elderly gastric cancer patients.

Entities:  

Keywords:  Elderly; Gastric cancer; Lymphadenectomy; Morbidity; Mortality; Prognosis; Propensity score matching; Survival

Year:  2017        PMID: 28656076      PMCID: PMC5472556          DOI: 10.4251/wjgo.v9.i6.257

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


Core tip: Inverse probability of treatment weighting (IPTW) attempts to reduce the bias due to confounding variables in estimates of treatment effects. In the present study, we compared the surgical outcomes and survival of elderly gastric cancer patients with that of general population after IPTW. The overall survival of pStage I gastric cancer patients in elderly was lower survival due to death of other diseases. We found that extent of lymph nodes dissection were independent prognostic factors. When the gastrectomy was performed in gastric cancer patients, we should recognized high mortality and comorbidities in that of elderly. This study was reviewed and approved by Nara Hospital, Kindai University review board on human research.

INTRODUCTION

Gastric cancer is the fifth most common malignancy after cancers of the lung, breast, colorectal area and prostate; patients in Eastern Asia account for about half of the world’s incidence[1]. In the past decade, incidence of gastric cancer in elderly patients has increased in Japan because of longer life spans of the general population[2]; decisions regarding gastric cancer surgeries in elderly patients have therefore also increased. Many surgeons are reluctant to have elderly patients undergo gastrectomies because of the considerably higher risk of complications from gastrectomies. There were some retrospective studies compared the outcomes of elderly gastric cancer patients to that of general populations, but the effects of age on morbidity, mortality from gastrectomy and/or prognosis are controversial, as no randomized studies have been conducted to our knowledge[3-18]. Also, no standard definition of “elderly” exists; thresholds vary from 65 to 80 years. Therefore, no standard guidelines for the treatment of elderly gastric cancer patients are available. Recently, the concept of propensity score matching (PSM) and inverse probability of treatment weighting (IPTW) has garnered some attention. PSM and IPTW attempts to reduce bias due to confounding variables in estimates of treatment effects[19]. In the present study, we first evaluated the clinicopathological features and surgical outcomes of gastric cancer treated in our department among patients aged 80 years and older, and compared them with those of patients aged 79 years and younger, after IPTW. We then analyzed these data to find optimal cut-off ages for elderly patients with gastric cancer.

MATERIALS AND METHODS

A total of 448 patients with histologically confirmed primary gastric carcinoma had gastrectomies in our department between 2005 and 2013. Of these, 115 patients were aged ≥ 80 years old (Group A), and 333 patients were aged ≤ 79 years old (Group B). All patients were American Society of Anesthesiologists risk less than three and there was no selection bias in each groups. Clinicopathological data for these patients were obtained from hospital records. Characteristics of two groups are shown and compared in Table 1. Postoperative complications were evaluated according to CTCAE Version 3.0; complications of grade ≥ 2 were regarded as significant[20]. Tumor location, clinical or pathological stage, degree of lymph node dissection (D0, D1 or D2), and curability (R0, R1 or R2) were assessed according to the Japanese Classification of Gastric Carcinoma, 13th, and then 14th editions[21,22]. Surgical mortality, morbidity, and hospital mortality were compared between two groups. Mean follow-up time for all patients was 34.57 mo (range: 0.16-113.13 mo). Recurrences were confirmed by computed tomography, tumor markers, and endoscopic examinations. Overall survival (OS) was defined as the time from the date of surgery to patient death (including surgery-associated death or hospital death), or the date of last available information concerning vital status. Cause-specific survival (CSS) is cancer survival in the absence of other cause of death or death from other cancers. CSS and OS were evaluated after IPTW method. This study was approved by our institute’s committee on human research (Approval No.399): Comprehensive informed consent was obtained from all patients when they admitted our hospital prior to surgery.
Table 1

Characteristics of patients in this study

Group AGroup BP value
Patients number115333
Sex (Male: female)73/42135/198
Mean age (yr)83.4465.87< 0.05
Occupied lesion0.693
U2481
M39114
L52138
Clinical stage (13th edition)0.446
IA40137
IB3065
II2048
IIIA939
IIIB826
IV818
Lymph nodes metastasis0.639
Negative76212
Positive39121
Histological type0.1224
Intestinal70175
Diffuse45158
Operative procedures0.074
Distal gastrectomy68218
Total gastrectomy3495
Proximal gastrectomy54
PPG311
Partial gastrectomy54
PD1
Lymph nodes dissection< 0.05
D0188
D16061
D236264
Curability< 0.05
Curative97310
Non-curative1823

PPG: Pylorus preserving gastrectomy; PD: Pancreaticoduodenectomy.

Characteristics of patients in this study PPG: Pylorus preserving gastrectomy; PD: Pancreaticoduodenectomy.

Statistical analysis

Clinicopathological variables between two groups were compared using the Mann-Whitney test or χ2 test. Survival analysis was carried out using Kaplan-Meier methods, and log-rank test was used to assess survival differences. P < 0.05 was considered significant. The propensity score (PS) was calculated using a multivariable logistic regression model with the two age groups as the dependent variables, and sex, cancer site, cT (14th edition), cN, clinical stage, operative procedures, and histological type (Lauren classification) as independent variables. Inverse probability of treatment weight (IPTW) was then calculated using PS. To evaluate the sensitivity and specificity of age in predicting 3-year OS, a time-dependent receiver operating characteristic (ROC) curve was calculated, and Youden’s index was estimated to determine the optimal cutoff age. Univariate and multivariate analyses used the Cox proportional hazard model for OS after IPTW method. A stepwise method was used to estimate predictive variables for OS in multivariate analysis. Statistical analysis was performed using STATA version 14 (Stata Corp LP, College Station, TX, United States), R version 3.1.0 (R Project for Statistical Computing, Vienna, Austria), and SPSS Statistics version 22 (IBM, Tokyo, Japan).

RESULTS

Patients’ characteristics are shown in Table 1. Degree of lymph node dissection was significantly more extensive in Group B (P < 0.05), and non-curative dissection was more frequency in Group A (P < 0.05). Optimal cutoff age for gastrectomy in terms of OS was 79.2 years old (AUC = 0.642, TP = 0.536, FP = 0.248, Figure 1). Therefore, we set the cut-off age at 80 years old.
Figure 1

Receiver operating characteristic curve for three years survival (AUC = 0.642, TP = 0.536, FP = 0.248).

Receiver operating characteristic curve for three years survival (AUC = 0.642, TP = 0.536, FP = 0.248). Postoperative complications are shown in Table 2. Respiratory complications and hospital death (including surgery-associated death) were more common in Group A (P < 0.05). After IPTW method, we found OS was significantly lower in Group A patients (P < 0.05; Figure 2A). The OS rates for Group A were 3-year: 46.6%, 5-year: 36.8%; those for Group B were 3-year: 74.8%, 5-year: 68.8%. Also, estimated CSS rates were significantly lower in Group A patients at 3-year, 5-year: 59.7% for Group A; and 3-year: 74.9%, 5-year: 69.1% in Group B (P < 0.05, Figure 2B). Among patients with pStage I disease, OS was significantly lower in Group A (P < 0.05, Figure 3A), whereas CSS was almost equal in both groups (Figure 3B); their estimated 5-year CSS and OS rates were CSS: 92.07%, OS: 62.18% in Group A and CSS, OS: 94.7% in Group B. OS was lower in Group A because of death by other cancers and other diseases, included pneumonia.
Table 2

Postoperative complications compared between two aged group

Group A (n = 115)Group B (n = 333)P value
Anastomotic leakage5 (4.3)8 (2.4)NS
Respiratory complications7 (6.0)7 (2.1)< 0.05
Other complications
Pancreatitis3 (2.6)7 (2.1)NS
Intraabdominal abscess0 (0)5 (1.5)NS
Ileus1 (0.87)1 (0.3)NS
Duodenal stump perforation1 (0.87)1 (0.3)NS
Hepatic failure1 (0.87)
Cholecystitis0 (0)1 (0.3)NS
Hospital death5 (4.3)3 (0.9)< 0.05
Figure 2

Overall survival (A) and cause-specific survival (B) in two aged group after IPTW method. OS and CSS were significantly lower in Group A than Group B (P < 0.05). OS: Overall survival; CSS: Cause-specific survival; IPTW: Inverse probability of treatment weighting.

Figure 3

Overall survival (A) and cause-specific survival (B) by age group among patients with pStage I gastric cancer who underwent gastrectomy. OS was significantly lower significantly lower in Group A than Group B after IPTW method (P < 0.05). OS: Overall survival; CSS: Cause-specific survival; IPTW: Inverse probability of treatment weighting.

Postoperative complications compared between two aged group Overall survival (A) and cause-specific survival (B) in two aged group after IPTW method. OS and CSS were significantly lower in Group A than Group B (P < 0.05). OS: Overall survival; CSS: Cause-specific survival; IPTW: Inverse probability of treatment weighting. Overall survival (A) and cause-specific survival (B) by age group among patients with pStage I gastric cancer who underwent gastrectomy. OS was significantly lower significantly lower in Group A than Group B after IPTW method (P < 0.05). OS: Overall survival; CSS: Cause-specific survival; IPTW: Inverse probability of treatment weighting. Among patients with pStage II-III disease, CSS and OS rates were almost equal in the two groups. The 5-year estimated CSS/OS rates (same rates) for patients with pStage II disease were 67.5% in Group A and 67.96% in Group B. Estimated 5-year CSS and OS rates for patients with pStage III disease were CSS: 42.4%, OS: 22.16% in Group A and CSS, OS: 23.23% in Group B. However, among patients with pStage IV disease, estimated OS/CSS (same rates) were significantly lower in Group A than in Group B; estimated 5-year CSS/OS were 27, 1% in Group B and 0% in Group A, respectively (Figure 4).
Figure 4

Cause-specific survival and overall survival by age group among patients with pStage IV gastric cancer who underwent gastrectomy; after IPTW method. CCS and OS were significantly lower in Group A than Group B (P < 0.05). OS: Overall survival; CSS: Cause-specific survival; IPTW: Inverse probability of treatment weighting..

Cause-specific survival and overall survival by age group among patients with pStage IV gastric cancer who underwent gastrectomy; after IPTW method. CCS and OS were significantly lower in Group A than Group B (P < 0.05). OS: Overall survival; CSS: Cause-specific survival; IPTW: Inverse probability of treatment weighting.. Univariate analysis of prognostic factors for OS in Group A is shown in Table 3. We found pStage, radicality, lymph node metastasis and extent of LN dissection significantly affected prognoses (P < 0.05). In multivariate analysis, pStage, histology, and extent of lymph node dissection were independent prognostic values for OS (Table 4).
Table 3

Univariate analysis of overall survival in Group A patients after IPTW method

VariantsHR95%CIP value
Sex (male:female)0.9410.515-1.7200.845
Tumor location (U:M:L)0.9670.779-1.2020.768
Operative procedures (total:others)1.0050.813-1.2420.961
Extent of LN dissection (D0:D1:D2)0.6610.4233-1.0320.009
pStage (13th edition) (I:II:III:IV)2.121.616-2.7820.001
Radicality (curative:non-curative)1.5290.083-0.2800.001
pLN metastasis (negative:positive)2.3321.274-4.2720.006
Postoperative complications (negative:positive)1.4320.642-3.1950.379
Histology (Lowren) (intestinal:diffuse)2.6371.470-4.7290.01
Table 4

Multivariate analysis of overall survival in Group A

Stepwise method (P < 0.1)
HR95%CIP value
pStage2.0141.516-2.6750.01
Histology (Lauren)2.0391.117-3.7200.02
Extent of LN dissection0.5280.343-0.8130.004
Univariate analysis of overall survival in Group A patients after IPTW method Multivariate analysis of overall survival in Group A

DISCUSSION

In the present study, we evaluated clinicopathological features and survival of patients aged 80 years and older, compared with patients aged 79 years and younger after IPTW. The optimal cut-off age for gastrectomies in elderly patients is controversial. The WHO classification defines “elderly” as older than 65 years old, “young-old” as 65-75 years old and “old-old” as older than 75 years[23]. In previously published studies of gastric cancer surgery in older patients, age thresholds ranged from 65 to 80 years old, so “elderly person” was not defined with regard to stomach cancer[4,5,7,8,11-17,24]. In the present study, we therefore used a survival ROC curve in patients with gastric cancer in terms of OS to determine the borderline age for gastrectomies, and concluded the optimal cut-off age is 79.2 years old, regardless of low AUC. Therefore, we divided the gastric cancer patients into two groups: 80 years and older (Group A, elderly group) and 79 years and younger (Group B, general population) in this study. In general, morbidity and mortality of gastric cancer patients after gastrectomy is controversial; mortality rates for elderly patients with gastric cancer who undergo gastrectomies range from 2% to 8.3% in the published data, which is compatible with our results[3-9,11,15]. Most reports did not find significant differences between the age groups, despite varying definitions of “elderly”. In the present study, surgical mortality was significantly higher in Group A (4.8%) than in Group B (0.9%), possibly because the mortality rate of Group B was less than 1% in our institution. Among postoperative complications, respiratory complications were more frequent in Group A in the present study. Although postoperative respiratory complications in elderly patients have been reported, only two reports noted a high complication rate specifically in elderly patients with gastric cancer[4,6,8,11,15]. Postoperative respiratory complications of elderly gastric cancer patients might be associated with surgical mortality; they therefore warrant more careful postoperative attention. In analyzing survival of patients with gastric cancer, we matched the two age groups using propensity scores; IPTW is considered to be a reliable statistical method for evaluating propensity scores[25]. Among patients with pStage I disease, OS was significantly lower in Group A, but CSS was not significantly different. Lower OS for elderly pStage I patients was due to surgical mortality, other causes of death, and death from other cancers. Therefore, careful observation after gastrectomy might improve survival of elderly patients with gastric cancer. In multivariate analysis, we found that extent of lymph node dissection was independent prognostic factors in elderly patients with gastric cancer. Also, postoperative complications, especially respiratory complication and hospital death were more common in elderly group. However, relationships between extent of lymph node dissection and postoperative morbidity, mortality and prognosis in elderly gastric cancer patients are controversial in the literature[3,4,7,11]. Most of these reports showed that more extended lymphadenectomy in elderly patients did not affect postoperative complication rates or prognosis. Only Eguchi et al[4] reported the extent of lymph node dissection in elderly gastric cancer patients to have influenced postoperative complications. Our findings indicate that more extended lymphadenectomy might improve survival in these patients if postoperative complications could be avoided. In conclusion, our retrospective study indicated that optimal cut-off ages for elderly patients with gastric cancer was eighty years old, and suggests that even if curative surgery is performed for pStage I disease in elderly gastric cancer patients, careful follow up is needed to stay abreast of other diseases, other cancers as outpatients. Additionally, more extensive lymph node dissection might improve prognosis of elderly patients with gastric cancer if postoperative complications could be minimized. However, postoperative complications lead to hospital death should be noted.

COMMENTS

Background

In the past decade, incidence of gastric cancer in elderly patients has increased in Japan. There was no randomized study compare the prognosis, morbidity and mortality of elderly gastric cancer patients and that of younger populations. Propensity score matching (PSM) and inversed probability of treatment weighting (IPTW) attempts to reduce bias due to confounding variables in estimates of treatment effects. They evaluated the clinicopathological features and surgical outcomes of gastric cancer treated in our department among patients aged 80 years and older, and compared them with those of patients aged 79 years and younger, after IPTW.

Research frontiers

There were some retrospective studies compared the outcomes of elderly gastric cancer patients to that of general populations, but the effects of age on morbidity, mortality from gastrectomy and/or prognosis are controversial, as no randomized studies have been conducted to our knowledge.

Innovations and breakthrough

PSM and IPTW attempt to reduce bias due to confounding variables in estimates of treatment effects. Quasi randomization is possible when they compared elderly group and younger group, statistically.

Applications

The clinical significance of elderly gastric cancer patients received gastrectomy were evaluated and revealed the higher postoperative complications and mortality in elderly patients, and more extensive lymph node dissection might improve prognosis of elderly patients with gastric cancer.

Peer-review

This is interesting to report the effects of age on survival and morbidity in gastric cancer patients undergoing gastrectomy. The author of this manuscript evaluated the gastric cancer patients received gastrectomy in elderly compared to that in younger population. Notably, this manuscript was compared the results of these patients used propensity score.
  19 in total

1.  Surgical mortality, survival, and quality of life after resection for gastric cancer in the elderly.

Authors:  C W Wu; S S Lo; K H Shen; M C Hsieh; W Y Lui; F K P'eng
Journal:  World J Surg       Date:  2000-04       Impact factor: 3.352

2.  Severity of complications after gastrectomy in elderly patients with gastric cancer.

Authors:  Tsutomu Hayashi; Takaki Yoshikawa; Toru Aoyama; Takashi Ogata; Haruhiko Cho; Akira Tsuburaya
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

3.  The outcome of surgical treatment for gastric carcinoma in the elderly.

Authors:  H Katai; M Sasako; T Sano; K Maruyama
Journal:  Jpn J Clin Oncol       Date:  1998-02       Impact factor: 3.019

4.  Gastric resection in the aged (> or = 80 years) with gastric carcinoma: a multivariate analysis of prognostic factors.

Authors:  H Kubota; T Kotoh; D K Dhar; R Masunaga; M Tachibana; H Tabara; H Kohno; N Nagasue
Journal:  Aust N Z J Surg       Date:  2000-04

5.  Surgery for gastric cancer in patients older than 80 years of age.

Authors:  K Hanazaki; M Wakabayashi; H Sodeyama; M Miyazawa; S Yokoyama; Y Sode; N Kawamura; M Ohtsuka; T Miyazaki
Journal:  Hepatogastroenterology       Date:  1998 Jan-Feb

6.  Surgical treatment for gastric carcinoma in the elderly.

Authors:  Arianna Coniglio; Guido Alberto Massimo Tiberio; Monica Busti; Giacomo Gaverini; Luca Baiocchi; Tullio Piardi; Maurizio Ronconi; Stefano Maria Giulini
Journal:  J Surg Oncol       Date:  2004-12-15       Impact factor: 3.454

7.  Comparison of surgical outcomes of gastric cancer in elderly and middle-aged patients.

Authors:  Chikara Kunisaki; Hirotoshi Akiyama; Masato Nomura; Goro Matsuda; Yuichi Otsuka; Hidetaka Andrew Ono; Hiroshi Shimada
Journal:  Am J Surg       Date:  2006-02       Impact factor: 2.565

8.  Postoperative complications in the oldest old gastric cancer patients.

Authors:  Hiroyuki Yamada; Tsuyoshi Shinohara; Masashi Takeshita; Tetsuya Umesaki; Yoshiro Fujimori; Kiyofumi Yamagishi
Journal:  Int J Surg       Date:  2013-04-18       Impact factor: 6.071

9.  Surgical outcomes of gastrectomy for elderly patients with gastric cancer.

Authors:  Hiroki Takeshita; Daisuke Ichikawa; Shuhei Komatsu; Takeshi Kubota; Kazuma Okamoto; Atsushi Shiozaki; Hitoshi Fujiwara; Eigo Otsuji
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

10.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

View more
  9 in total

1.  Application of Parametric Shared Frailty Models to Analyze Time-to-Death of Gastric Cancer Patients.

Authors:  Mesfin Esayas Lelisho; Geremew Muleta Akessa; Demeke Kifle Demissie; Samuel Fikadu Yermosa; Solomon Abebaw Andargie; Seid Ali Tareke; Digvijay Pandey
Journal:  J Gastrointest Cancer       Date:  2022-01-22

2.  At-home cancer screening: a solution for China and other developing countries with a large population and limited number of healthcare practitioners.

Authors:  Chao-Nan Qian
Journal:  Chin J Cancer       Date:  2017-08-21

3.  Is it safe to perform gastrectomy in gastric cancer patients aged 80 or older?: A meta-analysis and systematic review.

Authors:  Yixin Xu; Yibo Wang; Cheng Xi; Nianyuan Ye; Xuezhong Xu
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

4.  Analysis of Intestinal Flora and Levels of Epidermal Growth Factor Receptor, Interleukin-32, and Gastrin 17 in Patients with Gastric Cancer via Carbon Nanoparticle Laparoscopy.

Authors:  Liping Bai; Fubing Yu; Lixian Bai; Yinhui Zhang; Zhi Li; Peng Li; Xueyan Yang; Zhijian Ma
Journal:  Biomed Res Int       Date:  2021-05-12       Impact factor: 3.411

5.  Prognostic factors for elderly gastric cancer patients who underwent gastrectomy.

Authors:  Shunji Endo; Tomoki Yamatsuji; Yoshinori Fujiwara; Masaharu Higashida; Hisako Kubota; Hideo Matsumoto; Hironori Tanaka; Toshimasa Okada; Kazuhiko Yoshimatsu; Ken Sugimoto; Tomio Ueno
Journal:  World J Surg Oncol       Date:  2022-01-07       Impact factor: 2.754

6.  Laparoscopic vs open total gastrectomy for advanced gastric cancer following neoadjuvant therapy: A propensity score matching analysis.

Authors:  Hai-Tao Hu; Fu-Hai Ma; Jian-Ping Xiong; Yang Li; Peng Jin; Hao Liu; Shuai Ma; Wen-Zhe Kang; Yan-Tao Tian
Journal:  World J Gastrointest Surg       Date:  2022-02-27

7.  Characteristics and Predictors of Long-Time Survivors in Non-Metastatic Gastric Signet Ring Cell Carcinoma: A Large Population-Based Study.

Authors:  Qiuyan Weng; Zhe Li; Yaoyao Xie; Junming Guo; Yong Zhang; Guoliang Ye
Journal:  Int J Gen Med       Date:  2022-03-19

8.  The Clinical Impact of Advanced Age on the Postoperative Outcomes of Patients Undergoing Gastrectomy for Gastric Cancer: Analysis Across US Hospitals Between 2011-2017.

Authors:  David Uihwan Lee; Gregory Hongyuan Fan; Kevin Chang; Ki Jung Lee; John Han; Daniel Jung; Jean Kwon; Raffi Karagozian
Journal:  J Gastric Cancer       Date:  2022-07       Impact factor: 3.197

9.  Clinical significance of prognostic score based on age, tumor size, and grade in gastric cancer after gastrectomy.

Authors:  Jingfeng Lu; Yi Chen; Yanxia Liu; Junbin Ding; Zhenhao Piao; Weiyan Liu
Journal:  Cancer Manag Res       Date:  2018-10-08       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.